Could your own immune cells fight lung cancer? new trial tests safety
NCT ID NCT07202611
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial is testing whether lab-grown immune cells (dendritic and natural killer cells) are safe for people with advanced non-small cell lung cancer. Ten participants will receive injections of their own cultured cells. The main goal is to check for side effects, not yet to see if it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lab-grown dendritic cells and natural killer cells (immune cells)
What this could lead to
If it works, this could point toward a new immune-based treatment for advanced lung cancer that uses the patient's own cells.
What could go wrong
This is a very small, early Phase 2 trial focused on safety, not effectiveness. The treatment may not shrink tumors or improve survival, and side effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital Yunlin Branch
RECRUITINGHuwei, YUNLIN, 640, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••